Product Information

IBUPROFEN 800 MG TABLET is a generic product labeled by Legacy Pharmaceutical Packaging, LLC, priced at $0.0585 per EA under NDC 68645056354. Its NADAC has been published 453 times since Dec 20, 2017.

FDA first approved this application on Sep 15, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 800 MG TABLET

Ibuprofen
$0.0585per EA

Strength

800 mg/1

NDC

68645056354

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA091625

FDA Approved

9/15/2015

TE Code

AB

On Market Since

12/21/2015

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 800 MG TABLET has been published 453 times since Dec 20, 2017, and over the history we have for it it has risen 21.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0585 per EA
All-time high$0.0933 (Mar 11, 2020)
All-time low$0.0483 (Dec 20, 2017)
52-week high$0.0601
52-week low$0.0549
Median price$0.0673
Average price$0.0687
Largest weekly change-20.3% (Apr 17, 2024)
Weeks tracked453
Tracking sinceDec 20, 2017

Price History

1W

+5.1%

1M

+4.4%

3M

+3.1%

6M

+6.5%

1Y

-2.7%

3Y

-9.8%

5Y

-23.5%

All

+21.0%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of IBUPROFEN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Legacy Pharmaceutical Packaging, LLC, is $0.0585 per EA (NDC 68645056354), effective Aug 19, 2026.

How has the price of IBUPROFEN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has risen 21.0%. It has been tracked across 453 weekly CMS publications since Dec 20, 2017.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?

Since Dec 20, 2017, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0483 (Dec 20, 2017) to a high of $0.0933 (Mar 11, 2020), with a median of $0.0673 per EA.

Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?

Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 800 MG TABLET, is $0.0567 per EA — about 3% below IBUPROFEN 800 MG TABLET.

Who manufactures IBUPROFEN 800 MG TABLET?

IBUPROFEN 800 MG TABLET (NDC 68645056354) is labeled by Legacy Pharmaceutical Packaging, LLC, and CMS classifies it as a generic product.